GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brawn Biotech Ltd (BOM:530207) » Definitions » ROE % Adjusted to Book Value

Brawn Biotech (BOM:530207) ROE % Adjusted to Book Value : -22.87% (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Brawn Biotech ROE % Adjusted to Book Value?

Brawn Biotech's ROE % for the quarter that ended in Mar. 2024 was -26.99%. Brawn Biotech's PB Ratio for the quarter that ended in Mar. 2024 was 1.18. Brawn Biotech's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -22.87%.


Brawn Biotech ROE % Adjusted to Book Value Historical Data

The historical data trend for Brawn Biotech's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brawn Biotech ROE % Adjusted to Book Value Chart

Brawn Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.00 -8.13 -28.51 -16.24 -23.01

Brawn Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -48.78 - -24.48 - -22.87

Competitive Comparison of Brawn Biotech's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Brawn Biotech's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brawn Biotech's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Brawn Biotech's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Brawn Biotech's ROE % Adjusted to Book Value falls into.



Brawn Biotech ROE % Adjusted to Book Value Calculation

Brawn Biotech's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-27.15% / 1.18
=-23.01%

Brawn Biotech's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-26.99% / 1.18
=-22.87%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brawn Biotech ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Brawn Biotech's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Brawn Biotech (BOM:530207) Business Description

Traded in Other Exchanges
N/A
Address
Plot No. 30, Sector 33, Near Hero Honda Factory, Gurugram, HR, IND, 122001
Brawn Biotech Ltd is a healthcare company. It is primarily engaged in the business activity of wholesale of pharmaceutical and medical goods. The company's pharmaceutical goods cover product segments like Antibacterial, Cardiovascular, Anti-diabetic, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Anti-asthmatic, Antacids, Antimalarial, and Nutritionals. It markets pharmaceutical products in India and internationally. The company generates a major portion of its revenue from exports.

Brawn Biotech (BOM:530207) Headlines

No Headlines